Loading…
Storage stability of food-grade recombinant Lactococcus lactis NZ3900-fermented milk expressing K-ras mimotopes
K-ras mimotope expressed by Lactococcus lactis NZ3900 is a potential live oral vaccine developed to target specific K-ras mutations in colorectal cancer. However, the storage and delivery of live oral vaccines through the harsh gastrointestinal environment remains a challenge. Hence, this study was...
Saved in:
Published in: | Journal of food measurement & characterization 2024-03, Vol.18 (3), p.2184-2195 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | K-ras mimotope expressed by
Lactococcus lactis
NZ3900 is a potential live oral vaccine developed to target specific K-ras mutations in colorectal cancer. However, the storage and delivery of live oral vaccines through the harsh gastrointestinal environment remains a challenge. Hence, this study was aimed to evaluate the storage stability of
Lactococcus lactis
NZ3900 expressing K-ras mimotopes in fermented milk. The
L. lactis
NZ3900 expressing K-ras mimotopes was incorporated into skim milk for fermentation. The
L. lactis
-fermented milk was added with sucrose and stored for 42 days at 4 °C. The
L. lactis
NZ3900-fermented milk without sucrose was served as control. On day 28 of storage,
L. lactis
NZ3900-fermented milk with sucrose displayed high viability (8.05 log
10
CFU/mL), acceptable post-acidification activity (0.91% titratable acidity, pH 4.11), comparable physicochemical properties (13,949 mPa s viscosity, 71.4% syneresis, 5.83°Brix,
Δ
E = 1.68) with K-ras mimotope expression, and high survivability after simulated sequential digestion (82.5%). This suggests that fermented milk with sucrose is a suitable delivery carrier for this live oral vaccine. |
---|---|
ISSN: | 2193-4126 2193-4134 |
DOI: | 10.1007/s11694-023-02316-6 |